Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic targets

Circulation Journal

Volumn 73, Issue 3, 2009, Pages 394-403

  Maseri, Attilio ^a   Beltrame, John F ^b   Shimokawa, Hiroaki ^c  

^a Heart Care Foundation   (Italy)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary blood flow; Coronary circulation; Coronary vasospam; Myocardial ischemia; Vasospastic angina

Indexed keywords

ACETYLCHOLINE; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERGOMETRINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLERGOMETRINE;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; CORONARY ARTERY CONSTRICTION; HUMAN; ISCHEMIC HEART DISEASE; REVIEW; STABLE ANGINA PECTORIS; SYNDROME X; THROMBOSIS; THROMBOSIS PREVENTION; VARIANT ANGINA PECTORIS;

ANGINA PECTORIS, VARIANT; ANIMALS; CORONARY VASOSPASM; HUMANS; MYOCARDIAL ISCHEMIA; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 62649107662     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0033     Document Type: Review

References (83)

1. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999; 33: 1442-1452.
2. Friedberg CK. Diseases of the heart. 3rd edn. Philadelphia: WB Saunders; 1966.
3. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. A variant form of angina pectoris: Preliminary report. Am J Med 1959; 27: 375-388.
4. MacAlpin RN. Coronary arterial spasm: A historical perspective. J Hist Med Allied Sci 1980; 35: 288-311.
5. Round Table Discussion. Perspectives and guidelines in the investigation and treatment of patients with angina pectoris. In: Maseri A, Klassen G, Lesch M, editors. Primary and secondary angina pectoris. New York: Grune and Stratton; 1978; 439-443.
6. Shimokawa H, Yasuda S. Myocardial ischemia: Current concepts and future perspectives. J Cardiol 2008; 52: 67-78.
7. Takagi A, Arai K, Hosaka M, Komatsu Y, Gunnji K, Tanimoto K, et al. Noninvasive prediction of angiographic spasm provocation using trans-thoracic Doppler echocardiography in patients with coronary spastic angina. Circ J 2008; 72: 1640-1644.
8. Cheng T, Bashour T, Kelser GJ, Weiss L, Bacos J. Variant angina of Prinzmetal with normal coronary arteriograms: A variant of the variant. Circulation 1973; 47: 476-485.
9. Maseri A, Mimmo R, Chierchia S, Marchersi C, Pesola A, L'Abbate A. Coronary spasm as a cause of acute myocardial ischemia in man. Chest 1975; 68: 625-633.
10. Maseri A, Parodi O, Severi S, Pesola A. Transient transmural reduction of myocardial blood fow demonstrated by thallium-201 scintigraphy, as a cause of variant angina. Circulation 1976; 54: 280-288.
11. Maseri A, Severi S, De Nes M, L'Abbate A, Chierchia S, Marzilli M, et al. "Variant" angina: One aspect of a continuous spectrum of vasospastic myocardial ischemia: Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic fndings in 138 patients. Am J Cardiol 1978; 42: 1019-1034.
12. Hangartner JR, Charleston AJ, Davies MJ, Thomas AC. Morphological characteristics of clinically signifcant coronary artery stenosis in stable angina. Br Heart J 1986; 56: 501-508.
13. Deanfeld JE, Maseri A, Selwyn AP, Ribeiro P, Chierchia S, Krikler S, et al. Myocardial ischaemia during daily life in patients with stable angina: Its relation to symptoms and heart rate changes. Lancet 1983; 2: 753-758.
14. Chierchia S, Gallino A, Smith G, Deanfeld J, Morgan M, Croom M, et al. Role of heart rate in pathophysiology of chronic stable angina. Lancet 1984; 2: 1353-1357.
15. Epstein SE, Cannon RO 3rd, Watson RM, Leon MB, Bonow RO, Rosing DR. Dynamic coronary obstruction as a cause of angina pectoris: Implications regarding therapy. Am J Cardiol 1985; 55: 61B-68B.
16. Pupita G, Maseri A, Kaski JC, Galassi AR, Gavrielides S, Davies G, et al. Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris. N Engl J Med 1990; 323: 514-520.
17. el-Tamimi H, Davies GJ, Sritara P, Hackett D, Crea F, Maseri A. Inappropriate constriction of small coronary vessels as a possible cause of a positive exercise test early after successful coronary angioplasty. Circulation 1991; 84: 2307-2312.
18. Kern MJ, Deligonul U, Vandormael M, Labovitz A, Gudipati CV, Gabliani G, et al. Impaired coronary vasodilator reserve in the immediate postcoronary angioplasty period: Analysis of coronary artery fow velocity indexes and regional cardiac venous effux. J Am Coll Cardiol 1989; 13: 860-872.
19. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516.
20. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-1622.
21. Kim PJ, Seung KB, Kim DB, Her SH, Shin DI, Jang SW, et al. Clinical and angiographic characteristics of acute myocardial infarction caused by vasospastic angina without organic coronary heart disease. Circ J 2007; 71: 1383-1386.
22. Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction. Value of combined throm-bolytic and vasodilator therapy. N Engl J Med 1987; 317: 1055-1059.
23. Maseri A, L'Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, et al. Coronary vasospasm as a possible cause of myocardial infarction: A conclusion derived from the study of "preinfarction" angina. N Engl J Med 1978; 299: 1271-1277.
24. Bertrand M, LaBlanche J, Tilmant P, Thieuleux F, Delforge M, Carre A, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982; 65: 1299-1306.
25. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108.
26. Beltrame JF, Stewart S, Leslie S, Poropat S, Horowitz JD. Resolution of ST-segment elevation following intravenous administration of nitroglycerin and verapamil. Am J Cardiol 2002; 89: 452-455.
27. Wilson RF, Lesser JR, Laxson DD, White CW. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet 1989; 1: 807-811.
28. Pasceri V, Pristipino C, Pelliccia F, Granatelli A, Speciale G, Roncella A, et al. Effects of the nitric oxide donor nitroprusside on no-refow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol 2005; 95: 1358-1361.
29. Uren NG, Crake T, Lefroy DC, De Silva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994; 331: 222-227.
30. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991; 17: 499-506.
31. Buffon A, Rigattieri S, Santini SA, Ramazzotti V, Crea F, Giardina B, et al. Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X. Am J Physiol Heart Circ Physiol 2000; 279: H2627-H2633.
32. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction: The case for a distinction. Circulation 1990; 81: 1983-1991.
33. Clarke J, Davies G, Kerwin R, Hackett D, Larkin S, Dawbarn D, et al. Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet 1987; 1: 1057-1059.
34. Larkin SW, Clarke JG, Keogh BE, Araujo L, Rhodes C, Davies GJ, et al. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol 1989; 64: 956-958.
35. Gillespie MN, Booth DC, Friedman BJ, Cunningham MR, Jay M, DeMaria AN. fMLP provokes coronary vasoconstriction and myo-cardial ischemia in rabbits. Am J Physiol 1988; 254: 481-486.
36. Young MA, Knight DR, Vatner SF. Autonomic control of large coronary arteries and resistance vessels. Prog Cardiovasc Dis 1987; 30: 211-234.
37. Newman C, Maseri A, Hackett D, El-Tamimi H, Davies G. Response of angiographically normal and atherosclerotic left anterior descending coronary arteries to acetylcholine. Am J Cardiol 1990; 66: 1070-1076.
38. Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H, et al. Angina pectoris caused by coronary microvascular spasm. Lancet 1998; 351: 1165-1169.
39. McFadden E, Clarke J, Davies G, Kaski J, Haider A, Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 1991; 324: 648-654.
40. Kaski J, Maseri A, Vejar M, Crea F, Hackett D. Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. J Am Coll Cardiol 1989; 14: 1456-1463.
41. Ginsburg R, Bristow M, Kantrowitz N, Baim D, Harrison D. Histamine provocation of clinical coronary artery spasm: Implications concerning the pathogenesis of variant angina pectoris. Am Heart J 1981; 102: 819-822.
42. Crea F, Chierchia S, Kaski J, Davies G, Margonato A, Miran D, et al. Provocation of coronary spasm by dopamine in patients with active variant angina pectoris. Circulation 1986; 74: 262-269.
43. Yasue H, Touyama M, Kato H, Tanaka S, Akiyama F. Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptors-mediated coronary artery spasm: Documentation by coronary arteriography. Am Heart J 1976; 91: 148-155.
44. Yasue H, Nagao M, Omote S, Takizawa A, Miwa K, Tanaka S. Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion. Circulation 1978; 58: 56-62.
45. Shimokawa H, Tomoike H, Nabeyama S, Yamamoto H, Araki H, Nakamura M, et al. Coronary artery spasm induced in atherosclerotic minature swine. Science 1983; 221: 560-562.
46. Shimokawa H, Ito A, Fukumoto Y, Kadokami T, Nakaike R, Sakata M, et al. Chronic treatment with interleukin-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo: The role of platelet-derived growth factor. J Clin Invest 1996; 97: 769-776.
47. Hackett D, Larkin S, Chierchia S, Davies G, Kaski J, Maseri A. Induction of coronary artery spasm by a direct local action of ergonovine. Circulation 1987; 75: 577-582.
48. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986; 74: 955-963.
49. Mongiardo R, Finocchiaro ML, Beltrame J, Pristipino C, Lombardo A, Cianfone D, et al. Low incidence of serotonin-induced occlusive coronary artery spasm in patients with recent myocardial infarction. Am J Cardiol 1996; 78: 84-87.
50. Bertrand M, Lablanche J, Tilmant P, Thieuleux F, Delforge M, Chahine R. The provocation of coronary arterial spasm in patients with recent transmural myocardial infarction. Eur Heart J 1983; 4: 532-535.
51. Okumura K, Yasue H, Matsuyama K, Ogawa H, Morikami Y, Obata K, et al. Effect of acetylcholine on the highly stenotic coronary artery: Difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery. J Am Coll Cardiol 1992; 19: 752-758.
52. Nosaka H, Nobuyoshi M. Coronary arterial spasm and symptomatology in ischemic and non-ischemic heart diseases: Study of the ergonovine maleate provocative test in 3,000 consecutive patients. J Cardiogr Suppl 1987; 12: 35-47.
53. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: Role of exercise-induced coronary arterial spasm. Circulation 1979; 59: 938-948.
54. Girotti AL, Rutizky B, Schmidberg J, Crosatto J, Rosenbaum MB. Spontaneous remission in variant angina. Br Heart J 1981; 45: 517-521.
55. Waters DD, Bouchard A, Theroux P. Spontaneous remission is a frequent outcome of variant angina. J Am Coll Cardiol 1983; 2: 195-199.
56. Crossman D, Larkin S, Dashwood M, Davies G, Yacoub M, Maseri A. Responses of atherosclerotic human coronary arteries in vivo to the endothelium-dependent vasodilator substance P. Circulation 1991; 84: 2001-2010.
57. Frenneaux M, Kaski JC, Brown M, Maseri A. Refractory variant angina relieved by guanethidine and clonidine. Am J Cardiol 1988; 62: 832-833.
58. Lefroy D, Crake T, Haider A, Maseri A. Medical treatment of refractory coronary artery spasm. Cor Art Dis 1992; 3: 745-752.
59. Bertrand M, Lablanche J, Tilmant P, Ducloux G, Warembourg HJ, Soots G. Complete denervation of the heart (autotransplantation) for treatment of severe, refractory coronary spasm. Am J Cardiol 1981; 47: 1375-1378.
60. Freedman SB, Chierchia S, Rodriguez Plaza L, Bugiardini R, Smith G, Maseri A. Ergonovine-induced myocardial ischemia: No role for serotonergic receptors? Circulation 1984; 70: 178-183.
61. De Caterina R, Carpeggiani C, L'Abbate A. A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina: Evidence against the role for serotonin in the genesis of coronary vasospasm. Circulation 1984; 69: 889-894.
62. Chierchia S, de Caterina R, Crea F, Patrono C, Maseri A. Failure of thromboxane A2 blockade to prevent attacks of vasospastic angina. Circulation 1982; 66: 702-705.
63. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow fow phenomenon-a new coronary microvascular disorder. Cardiology 2002; 97: 197-202.
64. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88: 993-1003.
65. Maseri A. Myocardial stunning due to sudden emotional stress. N Engl J Med 2005; 352: 1923-1925; author reply 1923-1925.
66. Silverman ME, Flamm MDJ. Variant angina pectoris: Anatomic fndings and prognostic implications. Ann Intern Med 1971; 75: 339-343.
67. Trevi GP, Thiene G, Benussi P, Marini A, Caobelli A, Frasson F, et al. Prinzmetal's variant angina: Clinical, angiographic and pathologic correlations in two typical cases. Eur J Cardiol 1976; 4: 319-325.
68. Rizzon P, Rossi L, Calabrese P, Franchini G, DiBiase M. Angiographic and pathologic correlations in Prinzmetal's variants angina. Angiology 1978; 29: 486-490.
69. Auzepy P, Blondeau M, Albessard F. Electrocardiographic aspects suggessive of Prinzmetal's angina with normal coronary arteries at autopsy. Arch Mal Coeur Vaiss 1974; 67: 1107-1113 (in French).
70. El-Maraghi N, Sealey B. Recurrent myocardial infarction in a young man due to coronary arterial spasm demonstrated at autopsy. Circulation 1980; 61: 199-207.
71. Roberts WC, Curry RC, Isner JM, Waller BF, McMannus BM, Mariani-Constantini R, et al. Sudden death in Prinzmetal's angina with coronary spasm documented by angiography: Analysis of three necrospcopy patients. Am J Cardiol 1982; 50: 203-210.
72. Forman M, Oates J, Robertson D, Robertson R, Roberts L, Virmani R. Increased advential mast cells in a patient with coronary spasm. N Engl J Med 1985; 313: 1138-1141.
73. Petitier H, de Lajartre AY, Geslin P, Godin JF, Victor J, Crochet D, et al. Intimal coronary fbrous dysplasia and Prinzmetal's angina. Arch Mal Coeur Vaiss 1978; 71: 1053-1059 (in French).
74. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, et al. Inhibition of myosin phosphatase by upregulated rhokinase plays a key role for coronary artery spasm in a porcine model with interleukin-1β. Circulation 2000; 101: 1319-1323.
75. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002; 105: 1545-1547.
76. Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, Osada H, et al. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: A multicenter study. J Cardiovasc Pharmacol 2002; 40: 751-761.
77. Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol 2003; 41: 15-19.
78. Distante A, Maseri A, Severi S, Biagini A, Chierchia S. Management of vasospastic angina at rest with continuous infusion of isosorbide dinitrate: A double crossover study in a coronary care unit. Am J Cardiol 1979; 44: 533-539.
79. Parodi O, Maseri A, Simonetti I. Management of unstable angina at rest by verapamil: A double-blind cross-over study in coronary care unit. Br Heart J 1979; 41: 167-174.
80. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: Lessons from animal models. Jpn Circ J 2000; 64: 1-12.
81. Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol 2002; 39: 319-327.
82. Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005; 25: 1767-1775.
83. Shimokawa H, Rashid M. Development of Rho-kinase inhibitors for cardiovascular medicine. Trends Pharmacol Sci 2007; 28: 296-302.